- Home
- ORMP vs CTMX Comparison
ORMP vs CTMX Comparison
Compare ORMP & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- CTMX
- Stock Information
- Founded
- ORMP 2002
- CTMX 2008
- Country
- ORMP United States
- CTMX United States
- Employees
- ORMP N/A
- CTMX N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- CTMX Health Care
- Exchange
- ORMP Nasdaq
- CTMX Nasdaq
- Market Cap
- ORMP N/A
- CTMX 444.3M
- IPO Year
- ORMP N/A
- CTMX 2015
- Fundamental
- Price
- ORMP $2.19
- CTMX $2.27
- Analyst Decision
- ORMP Hold
- CTMX Strong Buy
- Analyst Count
- ORMP 1
- CTMX 2
- Target Price
- ORMP N/A
- CTMX $5.00
- AVG Volume (30 Days)
- ORMP 86.7K
- CTMX 2.7M
- Earning Date
- ORMP 08-15-2025
- CTMX 08-07-2025
- Dividend Yield
- ORMP N/A
- CTMX N/A
- EPS Growth
- ORMP N/A
- CTMX 128.27
- EPS
- ORMP N/A
- CTMX 0.49
- Revenue
- ORMP $2,000,000.00
- CTMX $147,557,000.00
- Revenue This Year
- ORMP N/A
- CTMX N/A
- Revenue Next Year
- ORMP N/A
- CTMX N/A
- P/E Ratio
- ORMP N/A
- CTMX $4.78
- Revenue Growth
- ORMP 196.74
- CTMX 23.81
- 52 Week Low
- ORMP $1.82
- CTMX $0.40
- 52 Week High
- ORMP $3.09
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- ORMP 47.76
- CTMX 50.77
- Support Level
- ORMP $2.12
- CTMX $2.08
- Resistance Level
- ORMP $2.25
- CTMX $2.44
- Average True Range (ATR)
- ORMP 0.09
- CTMX 0.24
- MACD
- ORMP -0.00
- CTMX -0.08
- Stochastic Oscillator
- ORMP 50.00
- CTMX 19.12
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.